Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, GA, USA; Emory+Children's Center for Cystic Fibrosis and Airway Disease Research, Emory University School of Medicine, Atlanta, GA, USA.
Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, GA, USA; Emory+Children's Center for Cystic Fibrosis and Airway Disease Research, Emory University School of Medicine, Atlanta, GA, USA.
Trends Microbiol. 2022 Oct;30(10):986-996. doi: 10.1016/j.tim.2022.03.009. Epub 2022 Apr 26.
Cystic fibrosis (CF) is a genetic disease that affects almost 100 000 people worldwide. CF patients suffer from chronic bacterial airway infections that are often polymicrobial and are the leading cause of mortality. Interactions between pathogens modulate expression of genes responsible for virulence and antibiotic resistance. One of the ways bacteria can interact is through contact-dependent systems, which secrete antibacterial proteins (effectors) that confer advantages to cells that harbor them. Here, we highlight recent work that describes effectors used by Gram-negative CF pathogens to eliminate competitor bacteria. Understanding the mechanisms of secreted effectors may lead to novel insights into the ecology of bacteria that colonize respiratory tracts and could also pave the way for the design of new therapeutics.
囊性纤维化(CF)是一种遗传疾病,影响着全球近 10 万人。CF 患者患有慢性细菌性气道感染,这些感染通常是多种微生物引起的,是导致死亡率的主要原因。病原体之间的相互作用会调节与毒力和抗生素耐药性相关的基因的表达。细菌相互作用的一种方式是通过接触依赖性系统,该系统分泌抗菌蛋白(效应物),使携带这些效应物的细胞获得优势。在这里,我们重点介绍了最近描述的革兰氏阴性 CF 病原体用来消除竞争细菌的效应物。了解分泌效应物的机制可能会深入了解定植在呼吸道的细菌的生态学,也为设计新的治疗方法铺平道路。